MARKET

THMO

THMO

ThermoGenesis Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.670
-0.040
-0.85%
Opening 13:50 07/16 EDT
OPEN
4.650
PREV CLOSE
4.710
HIGH
4.740
LOW
4.524
VOLUME
151.32K
TURNOVER
--
52 WEEK HIGH
14.18
52 WEEK LOW
1.630
MARKET CAP
29.72M
P/E (TTM)
-1.2811
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average THMO stock price target is 9.50 with a high estimate of 9.50 and a low estimate of 9.50.

EPS

THMO News

More
ThermoGenesis Announces Corning's Commercial Launch of the X-SERIES® Cell Processing Products Developed by ThermoGenesis
PR Newswire · 06/23 18:38
ThermoGenesis Announces Corning's Commercial Launch Of The X-SERIES Cell Processing Products Developed By ThermoGenesis
Innovative Density Gradient Media-Free & Buoyancy-Activated Cell Sorting (BACS) Technologies Improve Manufacturing Efficiency and Yield of Cell & Gene-Therapy Products RANCHO CORDOVA, Calif., June 23, 2020
Benzinga · 06/23 17:39
ThermoGenesis to Join Russell Microcap® Index
PR Newswire · 06/16 13:30
ThermoGenesis to Join Russell Microcap® Index
Benzinga · 06/16 12:33
ThermoGenesis Announces Filing of Patent Applications for Device that Improves the Accuracy of Lateral Flow Immunoassays (LFIA) in the Detection of COVID-19 Antibodies
PR Newswire · 06/11 13:30
ThermoGenesis files patent applications for detection of COVID-19 antibodies
Seeking Alpha - Article · 06/11 12:51
ThermoGenesis Announces That Results of ImmuneCyte's Licensed Neutralizing Antibody Therapeutics for COVID-19 Were Published in bioRxiv
PR Newswire · 06/08 18:07
ThermoGenesis Holdings Announces Change In Location Of 2020 Annual Meeting Of Stockholders
PR Newswire · 05/28 19:42

Industry

Office Equipment
+0.44%
Technology Equipment
-0.62%

Hot Stocks

Symbol
Price
%Change

About THMO

ThermoGenesis Holdings, Inc., formerly Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. It offers cell manufacturing tools and services in the global cell and gene therapy market.
More

Webull offers kinds of Thermogenesis Holdings Inc stock information, including NASDAQ:THMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, THMO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading THMO stock methods without spending real money on the virtual paper trading platform.